Zura Bio Ltd (ZURA)
4.40
-0.23
(-4.97%)
USD |
NASDAQ |
Oct 31, 16:00
4.395
0.00 (0.00%)
After-Hours: 20:00
Zura Bio EPS Diluted (Quarterly): -0.17 for June 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.17 |
| March 31, 2024 | -0.02 |
| December 31, 2023 | -0.144 |
| September 30, 2023 | -0.18 |
| Date | Value |
|---|---|
| June 30, 2023 | -1.31 |
| March 31, 2023 | -2.76 |
| September 30, 2022 | -4.830 |
| June 30, 2022 | -4.054 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-4.830
Minimum
Sep 2022
-0.02
Maximum
Mar 2024
-1.684
Average
-0.745
Median
EPS Diluted (Quarterly) Benchmarks
| Trevena Inc | -5.75 |
| Syndax Pharmaceuticals Inc | -0.80 |
| Arcus Biosciences Inc | -1.02 |
| Sagimet Biosciences Inc | -0.25 |
| CEL-SCI Corp | -0.14 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.33M |
| Total Expenses (Quarterly) | 11.76M |
| Enterprise Value | 138.27M |
| Earnings Yield | -11.70% |